Ferns Gordon A, Shabanian Sheida, Shams Abadi Milad Shahini, Farhat Ahmadshah, Arjmand Mohammad-Hassan
Division of Medical Education, Brighton & Sussex Medical School, Brighton, United Kingdom.
Department of Obstetrics and Gynecology, Faculty of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Gastrointest Tumors. 2021 Aug 5;8(4):177-186. doi: 10.1159/000517503. eCollection 2021 Oct.
Discoidin domain receptors (DDRs) belong to the receptor tyrosine kinases family and are activated by different types of collagens, which play roles in various physiological processes. An abnormal expression of DDRs is reported in different types of cancers. Despite many reports about the association and roles of high DDR expression levels in cancers, the prognostic values of DDRs are still unclear. This meta-analysis was performed to evaluate the prognostic effect of DDRs in different tissue cancers.
A literature search was performed in several related databases to find eligible English articles. Based on our research, 20 appropriate studies with 2,602 patients were selected till October 5, 2020. The pooled hazard ratio (HR) with a corresponding 95% confidence interval (CI) was computed to evaluate the strength of correlation between DDRs and survival of cancer patients.
Pooling results showed that a high DDR expression was significantly associated with poorer overall survival (OS) (HR = 1.304, 95% CI 1.007-1.69, = 0.04). Subgroup analysis based on cancer type revealed a significant link between a high DDR expression level and poor OS both in gastrointestinal (pooled HR = 1.78, 95% CI 1.214-2.624, = 0.003) and urological cancers (pooled HR = 1.42, 95% CI 1.062-1.82, = 0.018).
Our meta-analysis results suggest that high DDRs expression has the potential to be used as a biomarker of poor prognosis in cancers.
盘状结构域受体(DDRs)属于受体酪氨酸激酶家族,可被不同类型的胶原蛋白激活,在多种生理过程中发挥作用。据报道,DDRs在不同类型的癌症中存在异常表达。尽管有许多关于DDRs高表达水平在癌症中的关联和作用的报道,但其预后价值仍不明确。本荟萃分析旨在评估DDRs在不同组织癌症中的预后作用。
在多个相关数据库中进行文献检索,以查找符合条件的英文文章。根据我们的研究,截至2020年10月5日,共筛选出20项合适的研究,涉及2602例患者。计算合并风险比(HR)及相应的95%置信区间(CI),以评估DDRs与癌症患者生存率之间的关联强度。
汇总结果显示,DDRs高表达与较差的总生存期(OS)显著相关(HR = 1.304,95% CI 1.007 - 1.69,P = 0.04)。基于癌症类型的亚组分析显示,在胃肠道癌症(合并HR = 1.78,95% CI 1.214 - 2.624,P = 0.003)和泌尿系统癌症(合并HR = 1.42,95% CI 1.062 - 1.82,P = 0.018)中,DDRs高表达水平与较差的OS均存在显著关联。
我们的荟萃分析结果表明,DDRs高表达有可能作为癌症预后不良的生物标志物。